Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

390 recalls · Class II, newest first

Class II · Moderate risk

Niacin Extended-Release Tablets

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Completed Microbial contamination Sun Pharmaceutical Industries INC NDC 47335-613-81 D-0269-2024
Class II · Moderate risk

Mesalamine Delayed-Release Tablets

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Completed Microbial contamination Sun Pharmaceutical Industries INC NDC 63304-175-13 D-0268-2024
Class II · Moderate risk

Febuxostat Tablets 80 mg

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Completed Microbial contamination Sun Pharmaceutical Industries INC NDC 47335-722-83 D-0265-2024
Class II · Moderate risk

Febuxostat Tablets 40mg

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Completed Microbial contamination Sun Pharmaceutical Industries INC NDC 47335-721-83 D-0264-2024
Class II · Moderate risk

Cinacalcet Tablets 60mg

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Completed Microbial contamination Sun Pharmaceutical Industries INC NDC 47335-380-83 D-0263-2024
Class II · Moderate risk

Premier Value Tussin Cough DM

CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Ongoing Microbial contamination Seaway Pharma Inc. D-0215-2024
Class II · Moderate risk

Good Neighbor Pharmacy

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.

Ongoing Microbial contamination Pharma Nobis LLC NDC 46122-741-38 D-0227-2024
Class II · Moderate risk

Endometrin

cGMP deviations: potential for Microbial Contamination of Non-Sterile Products

Terminated Microbial contamination Ferring Pharmaceuticals Inc NDC 55566-6500-03 D-0879-2023
Class II · Moderate risk

Avant Foaming Hand Sanitizer

CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.

Terminated Microbial contamination Aire-Master of America Inc D-1355-2022

Recalls by year